S100A8 and bacterial pneumonia: Hence, targeted therapeutic strategies aimed at these specific inflammatory subsets, potentially through modulation of S100A8/A9 and CXCL8, or their associated signaling pathways, may offer more effective treatment strategies for mitigating the severe inflammatory pathology associated with bacterial pneumonia.